Evidence map›Paper›PMID 29225276›Full record

ArticleInternal medicine (Tokyo, Japan)2018

Mitral Regurgitation and Heart Failure as the First Presentation in a Patient with Features of Two Connective Tissue Disorders: A Rare Combination of Mucopolysaccharidosis and Osteogenesis Imperfecta?

Yasuhiro Hamatani, Junko Nakashima, Keiko Ohta-Ogo, Makoto Amaki, Masashi Koga, Daisetsu Aoyama, Kyohei Marume, Kenichiro Sawada, Yasuteru Nakashima, Atsushi Shibata and 9 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 1 institution in 1 country.

Yasuhiro HamataniDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.
Junko NakashimaDepartment of Pathology, National Cerebral and Cardiovascular Center, Japan.
Keiko Ohta-OgoDepartment of Pathology, National Cerebral and Cardiovascular Center, Japan.
Makoto AmakiDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.
Masashi KogaDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.
Daisetsu AoyamaDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.
Kyohei MarumeDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.
Kenichiro SawadaDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.
Yasuteru NakashimaDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.
Atsushi ShibataDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.
Atsushi OkadaDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.
Hiroyuki TakahamaDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.
Takuya HasegawaDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.
Yasuo SuganoDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.
Hideaki KanzakiDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.
Yoshihiko IkedaDepartment of Pathology, National Cerebral and Cardiovascular Center, Japan.
Satoshi YasudaDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.
Hatsue Ishibashi-UedaDepartment of Pathology, National Cerebral and Cardiovascular Center, Japan.
Toshihisa AnzaiDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.
National Cerebral and Cardiovascular Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Connective tissue disorders sometimes involve cardiovascular systems. This report describes the case of a middle-aged man with mitral regurgitation and heart failure. He had distinctive features of mucopolysaccharidosis type (MPS) III, but no gene mutations that were known to be associated with MPS. Meanwhile, he had a COL1A2 gene mutation that is associated with osteogenesis imperfecta (OI), and had some features that were compatible with OI. The patient might have had a rare connective tissue disorder with the characteristics of MPS III and OI, which was initially detected as a result of the cardiovascular manifestations.

Indexed as

Collagen Type IHeart FailureHumansMaleMiddle AgedMitral Valve InsufficiencyMucopolysaccharidosesOsteogenesis ImperfectaCOL1A2 protein, humanCollagen Type Iheart failuremitral regurgitationmucopolysaccharidosisosteogenesis imperfecta

Identifiers

PMID29225276
PMCPMC6120827
OpenAlexW2774573979

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.